Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,402
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ionis Pharmaceuticals Inc market cap is $4.43B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ionis Pharmaceuticals Inc 52 week high is $86.74 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ionis Pharmaceuticals Inc 52 week low is $26.53 as of November 22, 2026.
Ionis Pharmaceuticals Inc stock price today is $26.58.
Ionis Pharmaceuticals Inc stock price yesterday was $27.22.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ionis Pharmaceuticals Inc's P/E ratio is -7.98.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ionis Pharmaceuticals Inc P/B ratio is 11.2366.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ionis Pharmaceuticals Inc 50-day moving average is $40.77.